Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biomed Phys Eng Express ; 10(2)2024 Feb 13.
Artigo em Inglês | MEDLINE | ID: mdl-38306969

RESUMO

Objective.In this feasibility study, we explore an application of a Resistive Electrode Array (REA) for localization of a radioactive point source. The inverse problem posed by multichannel REA detection is studied from mathematical perspective and involves the questions of the minimal configuration of the conductive leads that can achieve this goal. The basic configuration consists of a circularly shaped REA with four opposite electrical lead-pairs at its perimeter.Approach.A robust mathematical reconstruction method for a 3D radioactive source relative to the REA is presented. The characteristic empirical Green's function for the detector response of the REA is determined by numerically solving Laplace equations with appropriate boundary conditions. Based on this model, Monte Carlo simulations of the inverse problem with Gaussian noise are performed and the overall accuracy of the localization is investigated.Main results.The results show a 3D error distribution of localization which is uniform in the (x,y)-plane of the REA and strongly correlated in the orthogonalz-axis. The overall accuracy decreases with higher distance of the source to the detector which is intuitive due to approximate flux dependence following the inverse square law. Further, a saturation in accuracy regarding the number of electrical leads and a linear dependence of the reconstruction error on the measurement noise level are observed.Significance.A broad range of REA detector configurations and their characteristics are investigated by this study for radioactive source localization allowing diverse practical applications with detector diameters ranging from millimeters to meters.


Assuntos
Método de Monte Carlo , Estudos de Viabilidade
2.
Med Phys ; 49(10): 6622-6634, 2022 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-35870154

RESUMO

BACKGROUND: Megavoltage computed tomography (MVCT) has been implemented on many radiotherapy treatment machines for on-board anatomical visualization, localization, and adaptive dose calculation. Implementing an MR-only workflow by synthesizing MVCT from magnetic resonance imaging (MRI) would offer numerous advantages for treatment planning and online adaptation. PURPOSE: In this work, we sought to synthesize MVCT (sMVCT) datasets from MRI using deep learning to demonstrate the feasibility of MRI-MVCT only treatment planning. METHODS: MVCTs and T1-weighted MRIs for 120 patients treated for head-and-neck cancer were retrospectively acquired and co-registered. A deep neural network based on a fully-convolutional 3D U-Net architecture was implemented to map MRI intensity to MVCT HU. Input to the model were volumetric patches generated from paired MRI and MVCT datasets. The U-Net was initialized with random parameters and trained on a mean absolute error (MAE) objective function. Model accuracy was evaluated on 18 withheld test exams. sMVCTs were compared to respective MVCTs. Intensity-modulated volumetric radiotherapy (IMRT) plans were generated on MVCTs of four different disease sites and compared to plans calculated onto corresponding sMVCTs using the gamma metric and dose-volume-histograms (DVHs). RESULTS: MAE values between sMVCT and MVCT datasets were 93.3 ± 27.5, 78.2 ± 27.5, and 138.0 ± 43.4 HU for whole body, soft tissue, and bone volumes, respectively. Overall, there was good agreement between sMVCT and MVCT, with bone and air posing the greatest challenges. The retrospective dataset introduced additional deviations due to sinus filling or tumor growth/shrinkage between scans, differences in external contours due to variability in patient positioning, or when immobilization devices were absent from diagnostic MRIs. Dose distributions of IMRT plans evaluated for four test cases showed close agreement between sMVCT and MVCT images when evaluated using DVHs and gamma dose metrics, which averaged to 98.9 ± 1.0% and 96.8 ± 2.6% analyzed at 3%/3 mm and 2%/2 mm, respectively. CONCLUSIONS: MVCT datasets can be generated from T1-weighted MRI using a 3D deep convolutional neural network with dose calculation on a sample sMVCT in close agreement with the MVCT. These results demonstrate the feasibility of using MRI-derived sMVCT in an MR-only treatment planning workflow.


Assuntos
Planejamento da Radioterapia Assistida por Computador , Tomografia Computadorizada por Raios X , Humanos , Imageamento por Ressonância Magnética/métodos , Redes Neurais de Computação , Dosagem Radioterapêutica , Planejamento da Radioterapia Assistida por Computador/métodos , Estudos Retrospectivos , Tomografia Computadorizada por Raios X/métodos
3.
Semin Cell Dev Biol ; 95: 151-159, 2019 11.
Artigo em Inglês | MEDLINE | ID: mdl-30502386

RESUMO

The pineal gland (PG) derives from the neural tube, like the rest of the central nervous system (CNS). The PG is specialized in synthesizing and secreting melatonin in a circadian fashion. The nocturnal elevation of melatonin is a highly conserved feature among species which proves its importance in nature. Here, we review a limited set of intrinsic and extrinsic regulatory elements that have been shown or proposed to influence the PG's melatonin production, as well as pineal ontogeny and homeostasis. Intrinsic regulators include the transcription factors CREB, Pax6 and NeuroD1. In addition, microglia within the PG participate as extrinsic regulators of these functions. We further discuss how these same elements work in other parts of the CNS, and note similarities and differences to their roles in the PG. Since the PG is a relatively well-defined and highly specialized organ within the CNS, we suggest that applying this comparative approach to additional PG regulators may be a useful tool for understanding complex areas of the brain, as well as the influence of the PG in both health and disease, including circadian functions and disorders.


Assuntos
Glândula Pineal/metabolismo , Transdução de Sinais , Animais , Humanos , Microglia/metabolismo , Fenótipo , Transdução de Sinais/genética , Fatores de Transcrição/metabolismo , Transcrição Gênica
4.
Bioconjug Chem ; 22(10): 2126-35, 2011 Oct 19.
Artigo em Inglês | MEDLINE | ID: mdl-21905741

RESUMO

Anthraquinone is a versatile scaffold to provide effective DNA binders. This planar system can be easily conjugated to protonable side chains: the nature of the lateral groups and their positions around the tricyclic moiety largely affect the DNA recognition process in terms of binding affinity and mode, as well as sequence and structure of the target nucleic acid. Starting from an anthracenedione system symmetrically functionalized with N-terminal lysyl residues, we incremented the length of side chains by introducing a Gly, Ala, or Phe spacer, characterized by different flexibility, lipophilicity, and bulkiness. Moreover, 2,6, 2,7, 1,8, and 1,5 regioisomers were examined to yield a small bis(lysyl-peptidyl) anthracenedione library. By merging spectroscopic, enzymatic, and cellular results, we showed that the proper combination of a basic aminoacid (Lys) with a more hydrophobic residue (Phe) can provide selective G-quadruplex recognition, in particular when side chains are located at positions 2,6 or 2,7. In fact, while these derivatives effectively bind G-quadruplex structures, they behave at the same time as rather poor double-stranded DNA intercalators. As a result, the Lys-Phe substituted anthraquinones are poorly cytotoxic but still able to promote a senescence mechanism in cancer cells. This combination of chemical and biological properties foresees potentially valuable applications in anticancer medicinal chemistry.


Assuntos
Antraquinonas/farmacologia , DNA/metabolismo , Quadruplex G , Substâncias Intercalantes/farmacologia , Oligopeptídeos/farmacologia , Antraquinonas/química , Antineoplásicos/química , Antineoplásicos/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Inibidores Enzimáticos/química , Inibidores Enzimáticos/farmacologia , Células HeLa , Humanos , Substâncias Intercalantes/química , Neoplasias/tratamento farmacológico , Oligopeptídeos/química , Telomerase/antagonistas & inibidores , Telomerase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...